Clinical Trial Update: Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update on combination therapy to prevent cardiovascular events in patients with systolic hypertension; study terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2011-05-17